Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
28.77
59.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Biohaven Pharmaceutical Holding Company Ltd
Balance Sheet Decomposition
Biohaven Pharmaceutical Holding Company Ltd
Current Assets | 511.3m |
Cash & Short-Term Investments | 436.9m |
Receivables | 7.5m |
Other Current Assets | 66.8m |
Non-Current Assets | 71.4m |
PP&E | 48.6m |
Intangibles | 19.8m |
Other Non-Current Assets | 3m |
Current Liabilities | 156.2m |
Accounts Payable | 17.3m |
Accrued Liabilities | 57.7m |
Other Current Liabilities | 81.2m |
Non-Current Liabilities | 42.7m |
Other Non-Current Liabilities | 42.7m |
Earnings Waterfall
Biohaven Pharmaceutical Holding Company Ltd
Revenue
|
0
USD
|
Operating Expenses
|
-781.3m
USD
|
Operating Income
|
-781.3m
USD
|
Other Expenses
|
34.7m
USD
|
Net Income
|
-746.6m
USD
|
Free Cash Flow Analysis
Biohaven Pharmaceutical Holding Company Ltd
USD | |
Free Cash Flow | USD |
BHVN Profitability Score
Profitability Due Diligence
Biohaven Pharmaceutical Holding Company Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Biohaven Pharmaceutical Holding Company Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
BHVN Solvency Score
Solvency Due Diligence
Biohaven Pharmaceutical Holding Company Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Biohaven Pharmaceutical Holding Company Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BHVN Price Targets Summary
Biohaven Pharmaceutical Holding Company Ltd
According to Wall Street analysts, the average 1-year price target for BHVN is 66.54 USD with a low forecast of 55.55 USD and a high forecast of 84 USD.
Dividends
Current shareholder yield for BHVN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
BHVN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. The company is headquartered in New Haven, Connecticut and currently employs 928 full-time employees. The company went IPO on 2017-05-04. The firm has a portfolio of therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. The firm's Neuroinnovation portfolio includes NURTEC ODT (rimegepant) for the acute and preventive treatment of migraine and a pipeline of product candidates across five platforms: calcitonin gene related peptide (CGRP) receptor antagonism for the acute and preventive treatment of migraine as well as other pain-related disorders and non-migraine indications; glutamate modulation for obsessive-compulsive disorder (OCD); myeloperoxidase (MPO) inhibition for multiple system atrophy (MSA) and amyotrophic lateral sclerosis (ALS); Kv7 Ion Channel Activators (Kv7) to target indications including epilepsy, pain disorders and effective disorders; and Myostatin offers a natural protein that limits skeletal muscle growth.